TransMedics Group, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $189.95Mn |
Net Profits | $14.68Mn |
Net Profit Margins | 7.73% |
TransMedics Group, Inc. Common Stock’s revenue jumped 20.7% since last year same period to $189.95Mn in the Q2 2026. On a quarterly growth basis, TransMedics Group, Inc. Common Stock has generated 9.21% jump in its revenue since last 3-months.
TransMedics Group, Inc. Common Stock’s net profit fell -57.94% since last year same period to $14.68Mn in the Q2 2026. On a quarterly growth basis, TransMedics Group, Inc. Common Stock has generated 100.71% jump in its net profits since last 3-months.
TransMedics Group, Inc. Common Stock’s net profit margin fell -65.15% since last year same period to 7.73% in the Q2 2026. On a quarterly growth basis, TransMedics Group, Inc. Common Stock has generated 83.79% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.5 |
EPS Estimate Current Year | 0.5 |
TransMedics Group, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.5 - a -18.03% fall from last quarter’s estimates.
TransMedics Group, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 0.5.
Key Ratios
Earning Per Share (EPS) | 0.44 |
TransMedics Group, Inc. Common Stock’s earning per share (EPS) fell -52.17% since last year same period to 0.44 in the Q2 2026. This indicates that the TransMedics Group, Inc. Common Stock has generated -52.17% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-04 | 0.5 | 0.44 | -12% |
2026-05-05 | 0.61 | 0.3 | -50.82% |
